Xaar shares slide 22% as some Chinese customers investigated over import duties

Xaar plc (XAR.L) said today it has been informed that certain of its Chinese customers, accounting for around 15% of Xaar's total revenue, are being investigated by the Chinese customs authorities over alleged non-payment of import duty.

Xaar itself is not a party to the investigation but is co-operating with customs officials.

The Cambridge-headquartered company’s shares dropped 22% after the news to 121.50p, valuing the company at around £73m. It has been a torrid few months for the inkjet specialist’s shares. In early March they reached almost 340p, but have steadily declined since then, along with but more than other high tech shares.

Xaar was notified by the authorities of the impending investigation on 19th July, the company said in a statement to the London Stock Exchange, but at that time did not consider it would have a material effect on sales.

High growth

“Digital printing is a high profile growth industry in China which has attracted similar investigations before, with little or no impact on the company,” it said.

”It has now become apparent, however, that the current investigation is being coordinated by central customs authorities, rather than by local officials as has previously been the case. This is likely to increase the period of the investigation and its impact on current trading which remains below expectations”.

”It is the company's aim that results for the full year should be similar to those reported for 2005 but, until the current investigation has run its course, it is not possible to quantify accurately the impact it will have on the timing of sales over the remainder of the year”.

A further update will be issued with the interim results which are scheduled for release on 13th September.

9th August

Previous articles
Prelude Trust's portfolio sheds 11%; Board orders investigation of options going forward
AstraZeneca wraps up CAT; appoints new top management
AVEVA rides the resource boom to record revenue, profit; plans share split
NextGen buys US-based Proteomic Research for $1.7m; completes share placing
Briefs: Sareum boosted by Johnson & Johnson contract extension; NXT’s flat speakers into another Citreon
ANT product shipments jump as losses widen; broadening offerings
Cambridge Antibody turns profit ahead of AstraZeneca takeover
Briefs: Autonomy secures big contract; new CSR chip supports Bluetooth speech recognition
Bango’s revenue grows in 06/07; but losses higher as market takes time to develop
Briefs: Agilent, Spirent join CSR in EGPS Forum; Stem Cell Sciences launches iStem
Subscribe

 

Corporate profiles

 • Ware Anthony Rust


Gareth Brookman
Board Account Director


WAR provides a seamless communications service for a host of clients in B2C, B2B and healthcare sectors, bringing together talented and creative individuals with specific expertise in their own fields. The agency disciplines of advertising, design, public relations, interactive and direct marketing

[Ware Anthony Rust's profile]


Top20 Index




Currently: 79.47